A simple risk‐based reimbursement system for kidney transplant
Transplant centers were challenged by the Executive Order on Advancing Kidney health to increase access to kidney transplant (KTx) by accepting higher risk patients and organs. However, Medicare reimbursement for KTx does not include adjustment for major complicating comorbidities (MCCs) like other...
Gespeichert in:
| Veröffentlicht in: | Clinical transplantation 2021-01, Vol.35 (1), p.e14068-n/a |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 1 |
| container_start_page | e14068 |
| container_title | Clinical transplantation |
| container_volume | 35 |
| creator | Schwantes, Issac R. Schnitzler, Mark A. Lentine, Krista L. Balakrishnan, Ramji Reed, Alan I. Axelrod, David A. |
| description | Transplant centers were challenged by the Executive Order on Advancing Kidney health to increase access to kidney transplant (KTx) by accepting higher risk patients and organs. However, Medicare reimbursement for KTx does not include adjustment for major complicating comorbidities (MCCs) like other transplants. The prevalence of MCCs was assessed for KTx performed from 10/15 to 10/19 at a single academic center, using Medicare ICD10 MCC criteria exclusive of end‐stage kidney disease. KTx hospital resource utilization and estimated margin, assuming Medicare reimbursement, were determined for cases with and without MCC. Among 260 KTx recipients, 49 (19%) had an MCC. Patients with MCCs had longer wait times (1121 days vs 703 days, P |
| doi_str_mv | 10.1111/ctr.14068 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2435188148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2435188148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3258-d1486efb3bc6d4a3088d6f18893502c40ceef6a50667a2fc20a515ae380d059e3</originalsourceid><addsrcrecordid>eNp1kM1KxDAQx4Mo7rp68AWkRz3UnSRNTG8ui1-wIMh6Dmk6hbr9WJMW6c1H8Bl9EqNdvTmXGYYfvxn-hJxSuKSh5rZzlzQBqfbIlPI0jQEo2ydTSIGFWfIJOfL-JWwlleKQTDhToLhkU3K9iHxZbyuMXOk3n-8fmfGYRw7LOuudxxqbLvKD77COitZFmzJvcIg6Zxq_rUzTHZODwlQeT3Z9Rp5vb9bL-3j1ePewXKxiy5lQcU4TJbHIeGZlnhgOSuWyoEqlXACzCVjEQhoBUl4ZVlgGRlBhkCvIQaTIZ-R89G5d-9qj73RdeotV-AHb3muWcBF04UxAL0bUutZ7h4XeurI2btAU9HdgOgSmfwIL7NlO22c15n_kb0IBmI_AW1nh8L9JL9dPo_ILPqV1cA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435188148</pqid></control><display><type>article</type><title>A simple risk‐based reimbursement system for kidney transplant</title><source>Access via Wiley Online Library</source><creator>Schwantes, Issac R. ; Schnitzler, Mark A. ; Lentine, Krista L. ; Balakrishnan, Ramji ; Reed, Alan I. ; Axelrod, David A.</creator><creatorcontrib>Schwantes, Issac R. ; Schnitzler, Mark A. ; Lentine, Krista L. ; Balakrishnan, Ramji ; Reed, Alan I. ; Axelrod, David A.</creatorcontrib><description>Transplant centers were challenged by the Executive Order on Advancing Kidney health to increase access to kidney transplant (KTx) by accepting higher risk patients and organs. However, Medicare reimbursement for KTx does not include adjustment for major complicating comorbidities (MCCs) like other transplants. The prevalence of MCCs was assessed for KTx performed from 10/15 to 10/19 at a single academic center, using Medicare ICD10 MCC criteria exclusive of end‐stage kidney disease. KTx hospital resource utilization and estimated margin, assuming Medicare reimbursement, were determined for cases with and without MCC. Among 260 KTx recipients, 49 (19%) had an MCC. Patients with MCCs had longer wait times (1121 days vs 703 days, P < .001); however, there were no differences in age, gender, race, or diagnosis. Donor characteristics associated with an MCC included greater cold ischemic time (1042 vs 670 minutes, P < .001) and fewer living donor KTx (9% vs 32%, P < .001). KTx cost, exclusive of organ acquisition, was 31% higher (MCC: $38 293 vs No MCC: $29 132) and estimated margin was markedly lower (‐$7750 vs ‐$1001, P = .001). In conclusion, KTx with qualifying MCCs resulted in significant financial losses and modification of KTx payment methodology to align with other organ transplants is needed.</description><identifier>ISSN: 0902-0063</identifier><identifier>EISSN: 1399-0012</identifier><identifier>DOI: 10.1111/ctr.14068</identifier><identifier>PMID: 32808362</identifier><language>eng</language><publisher>Denmark</publisher><subject>diagnosis‐related group ; economics ; finance ; medicare ; organ acceptance</subject><ispartof>Clinical transplantation, 2021-01, Vol.35 (1), p.e14068-n/a</ispartof><rights>2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><rights>2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3258-d1486efb3bc6d4a3088d6f18893502c40ceef6a50667a2fc20a515ae380d059e3</citedby><cites>FETCH-LOGICAL-c3258-d1486efb3bc6d4a3088d6f18893502c40ceef6a50667a2fc20a515ae380d059e3</cites><orcidid>0000-0001-5684-0613 ; 0000-0002-9423-4849</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fctr.14068$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fctr.14068$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32808362$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwantes, Issac R.</creatorcontrib><creatorcontrib>Schnitzler, Mark A.</creatorcontrib><creatorcontrib>Lentine, Krista L.</creatorcontrib><creatorcontrib>Balakrishnan, Ramji</creatorcontrib><creatorcontrib>Reed, Alan I.</creatorcontrib><creatorcontrib>Axelrod, David A.</creatorcontrib><title>A simple risk‐based reimbursement system for kidney transplant</title><title>Clinical transplantation</title><addtitle>Clin Transplant</addtitle><description>Transplant centers were challenged by the Executive Order on Advancing Kidney health to increase access to kidney transplant (KTx) by accepting higher risk patients and organs. However, Medicare reimbursement for KTx does not include adjustment for major complicating comorbidities (MCCs) like other transplants. The prevalence of MCCs was assessed for KTx performed from 10/15 to 10/19 at a single academic center, using Medicare ICD10 MCC criteria exclusive of end‐stage kidney disease. KTx hospital resource utilization and estimated margin, assuming Medicare reimbursement, were determined for cases with and without MCC. Among 260 KTx recipients, 49 (19%) had an MCC. Patients with MCCs had longer wait times (1121 days vs 703 days, P < .001); however, there were no differences in age, gender, race, or diagnosis. Donor characteristics associated with an MCC included greater cold ischemic time (1042 vs 670 minutes, P < .001) and fewer living donor KTx (9% vs 32%, P < .001). KTx cost, exclusive of organ acquisition, was 31% higher (MCC: $38 293 vs No MCC: $29 132) and estimated margin was markedly lower (‐$7750 vs ‐$1001, P = .001). In conclusion, KTx with qualifying MCCs resulted in significant financial losses and modification of KTx payment methodology to align with other organ transplants is needed.</description><subject>diagnosis‐related group</subject><subject>economics</subject><subject>finance</subject><subject>medicare</subject><subject>organ acceptance</subject><issn>0902-0063</issn><issn>1399-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kM1KxDAQx4Mo7rp68AWkRz3UnSRNTG8ui1-wIMh6Dmk6hbr9WJMW6c1H8Bl9EqNdvTmXGYYfvxn-hJxSuKSh5rZzlzQBqfbIlPI0jQEo2ydTSIGFWfIJOfL-JWwlleKQTDhToLhkU3K9iHxZbyuMXOk3n-8fmfGYRw7LOuudxxqbLvKD77COitZFmzJvcIg6Zxq_rUzTHZODwlQeT3Z9Rp5vb9bL-3j1ePewXKxiy5lQcU4TJbHIeGZlnhgOSuWyoEqlXACzCVjEQhoBUl4ZVlgGRlBhkCvIQaTIZ-R89G5d-9qj73RdeotV-AHb3muWcBF04UxAL0bUutZ7h4XeurI2btAU9HdgOgSmfwIL7NlO22c15n_kb0IBmI_AW1nh8L9JL9dPo_ILPqV1cA</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Schwantes, Issac R.</creator><creator>Schnitzler, Mark A.</creator><creator>Lentine, Krista L.</creator><creator>Balakrishnan, Ramji</creator><creator>Reed, Alan I.</creator><creator>Axelrod, David A.</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5684-0613</orcidid><orcidid>https://orcid.org/0000-0002-9423-4849</orcidid></search><sort><creationdate>202101</creationdate><title>A simple risk‐based reimbursement system for kidney transplant</title><author>Schwantes, Issac R. ; Schnitzler, Mark A. ; Lentine, Krista L. ; Balakrishnan, Ramji ; Reed, Alan I. ; Axelrod, David A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3258-d1486efb3bc6d4a3088d6f18893502c40ceef6a50667a2fc20a515ae380d059e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>diagnosis‐related group</topic><topic>economics</topic><topic>finance</topic><topic>medicare</topic><topic>organ acceptance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwantes, Issac R.</creatorcontrib><creatorcontrib>Schnitzler, Mark A.</creatorcontrib><creatorcontrib>Lentine, Krista L.</creatorcontrib><creatorcontrib>Balakrishnan, Ramji</creatorcontrib><creatorcontrib>Reed, Alan I.</creatorcontrib><creatorcontrib>Axelrod, David A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwantes, Issac R.</au><au>Schnitzler, Mark A.</au><au>Lentine, Krista L.</au><au>Balakrishnan, Ramji</au><au>Reed, Alan I.</au><au>Axelrod, David A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A simple risk‐based reimbursement system for kidney transplant</atitle><jtitle>Clinical transplantation</jtitle><addtitle>Clin Transplant</addtitle><date>2021-01</date><risdate>2021</risdate><volume>35</volume><issue>1</issue><spage>e14068</spage><epage>n/a</epage><pages>e14068-n/a</pages><issn>0902-0063</issn><eissn>1399-0012</eissn><abstract>Transplant centers were challenged by the Executive Order on Advancing Kidney health to increase access to kidney transplant (KTx) by accepting higher risk patients and organs. However, Medicare reimbursement for KTx does not include adjustment for major complicating comorbidities (MCCs) like other transplants. The prevalence of MCCs was assessed for KTx performed from 10/15 to 10/19 at a single academic center, using Medicare ICD10 MCC criteria exclusive of end‐stage kidney disease. KTx hospital resource utilization and estimated margin, assuming Medicare reimbursement, were determined for cases with and without MCC. Among 260 KTx recipients, 49 (19%) had an MCC. Patients with MCCs had longer wait times (1121 days vs 703 days, P < .001); however, there were no differences in age, gender, race, or diagnosis. Donor characteristics associated with an MCC included greater cold ischemic time (1042 vs 670 minutes, P < .001) and fewer living donor KTx (9% vs 32%, P < .001). KTx cost, exclusive of organ acquisition, was 31% higher (MCC: $38 293 vs No MCC: $29 132) and estimated margin was markedly lower (‐$7750 vs ‐$1001, P = .001). In conclusion, KTx with qualifying MCCs resulted in significant financial losses and modification of KTx payment methodology to align with other organ transplants is needed.</abstract><cop>Denmark</cop><pmid>32808362</pmid><doi>10.1111/ctr.14068</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-5684-0613</orcidid><orcidid>https://orcid.org/0000-0002-9423-4849</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0902-0063 |
| ispartof | Clinical transplantation, 2021-01, Vol.35 (1), p.e14068-n/a |
| issn | 0902-0063 1399-0012 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2435188148 |
| source | Access via Wiley Online Library |
| subjects | diagnosis‐related group economics finance medicare organ acceptance |
| title | A simple risk‐based reimbursement system for kidney transplant |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A21%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20simple%20risk%E2%80%90based%20reimbursement%20system%20for%20kidney%20transplant&rft.jtitle=Clinical%20transplantation&rft.au=Schwantes,%20Issac%20R.&rft.date=2021-01&rft.volume=35&rft.issue=1&rft.spage=e14068&rft.epage=n/a&rft.pages=e14068-n/a&rft.issn=0902-0063&rft.eissn=1399-0012&rft_id=info:doi/10.1111/ctr.14068&rft_dat=%3Cproquest_cross%3E2435188148%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2435188148&rft_id=info:pmid/32808362&rfr_iscdi=true |